Lutetium Lu 177 dotatate
Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Lutetium Lu 177 dotatate
Trade Name Lutathera
Synonyms LuTate|177Lu-Octreotate|177 Lu-DOTA-Tyr3-octreotate|177Lu-DOTATATE
Drug Descriptions

Lutathera (lutetium Lu 177 dotatate) is a radiolabeled somatostatin analog that may selectively kill somatostatin receptor-positive tumor cells (PMID: 28076709). Lutathera (lutetium Lu 177 dotatate) is FDA approved for use in patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (FDA.gov).

DrugClasses
CAS Registry Number 437608-50-9
NCIT ID C95020

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
131I-MIBG + Lutetium Lu 177 dotatate 131I-MIBG Lutetium Lu 177 dotatate 0 1
Atezolizumab + Carboplatin + Etoposide + Lutetium Lu 177 dotatate Atezolizumab Carboplatin Etoposide Lutetium Lu 177 dotatate 0 1
Avelumab + Lutetium Lu 177 dotatate Avelumab Lutetium Lu 177 dotatate 0 1
Cabozantinib + Lutetium Lu 177 dotatate Cabozantinib Lutetium Lu 177 dotatate 0 1
Carboplatin + Etoposide + Lutetium Lu 177 dotatate + Tislelizumab Carboplatin Etoposide Lutetium Lu 177 dotatate Tislelizumab 0 0
Decitabine and Cedazuridine + Lutetium Lu 177 dotatate Decitabine and Cedazuridine Lutetium Lu 177 dotatate 0 1
Fulvestrant + Lutetium Lu 177 dotatate Fulvestrant Lutetium Lu 177 dotatate 0 1
Lanreotide acetate + Lutetium Lu 177 dotatate Lanreotide acetate Lutetium Lu 177 dotatate 0 1
Lutetium Lu 177 dotatate Lutetium Lu 177 dotatate 0 22
Lutetium Lu 177 dotatate + Nivolumab Lutetium Lu 177 dotatate Nivolumab 0 1
Lutetium Lu 177 dotatate + Octreotide acetate Lutetium Lu 177 dotatate Octreotide acetate 0 2
Lutetium Lu 177 dotatate + Olaparib Lutetium Lu 177 dotatate Olaparib 0 3
Lutetium Lu 177 dotatate + Pembrolizumab Lutetium Lu 177 dotatate Pembrolizumab 0 1
Lutetium Lu 177 dotatate + Peposertib Lutetium Lu 177 dotatate Peposertib 0 1
Lutetium Lu 177 dotatate + Sunitinib Lutetium Lu 177 dotatate Sunitinib 0 1
Lutetium Lu 177 dotatate + Talazoparib Lutetium Lu 177 dotatate Talazoparib 0 1
Lutetium Lu 177 dotatate + Triapine Lutetium Lu 177 dotatate Triapine 0 2


Additional content available in Icon for CKB-BoostCKB BOOST